This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor ....
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hester Biosciences Ltd has scheduled an investor teleconference call for Friday, 15 May 2026 at 2:00 PM IST. The call will discuss Q4 and FY2026 financial results for the quarter and year ended 31 March 2026. The company's top management including CEO & Managing Director Rajiv Gandhi, Executive Director Priya Gandhi, and CFO Ashish Desai will participate in the call. The conference is being coordinated by ICICI Securities with diamond pass registration required for participation. This disclosure is made under SEBI's Regulation 30 for material events and shareholder communications.
This is a routine investor relations disclosure indicating transparency in communicating financial performance. The announcement itself does not contain any financial figures or material developments, so it has no direct short-term impact on the stock. However, it confirms that Q4 and FY2026 results will be announced before 15 May 2026.